Pharmacological inhibition of PDE4B by 0.3 ​mg/kg A33 i.p. administered 30 ​min after traumatic brain injury induction, induced anti-inflammatory markers (e.g., Arginase-1) in phagocytes and limited lesion size [[42], [43], [44]]. Here, PDE4B is linked to brain injury.